论文信息 - Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan - 字舞流文

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

J. Huebner | H. Heinzer | M. Baier | R. Andreesen | A. Stenzl | F. Eichhorn | A. Reichle | A. Bakhshandeh-Bath | W. Wieland | S. Feyerabend | W. Herr | R. Oberneder | M. Vogelhuber | K. Birkholz | K. Schmidt | T. Suedhoff | A. Ruebel | M. Schulze | S. Mueller